The dynamics of a bacterial population exposed to the minimum inhibitory concentration (MIC) of an antibiotic is an important issue in pharmacological research. Therefore, a novel antibiotic susceptibility test is urgently needed that can both precisely determine the MIC and accurately select antibiotic-resistant strains from clinical bacterial populations. For this purpose, we developed a method based on Fick's laws of diffusion using agar plates containing a linear gradient of antibiotic. The gradient plate contained two layers. The bottom layer consisted of 15 mL agar containing the appropriate concentration of enrofloxacin and allowed to harden in the form of a wedge with the plate slanted such that the entire bottom was just covered. The upper layer consisted of 15 mL plain nutrient agar added with the plate held in the horizontal position. After allowing vertical diffusion of the drug from the bottom agar layer for 12 h, the enrofloxacin concentration was diluted in proportion to the ratio of the agar layer thicknesses. The uniform linear concentration gradient was verified by measuring the enrofloxacin concentration on the agar surface. When heavy bacterial suspensions were spread on the agar surface and incubated for more than 12 h, only resistant cells were able to form colonies beyond the boundary of confluent growth of susceptible cells. In this way, the true MIC of enrofloxacin was determined. The MICs obtained using this linear gradient plate were consistent with those obtained using conventional antibiotic susceptibility tests. Discrete colonies were then spread onto a gradient plate with higher antibiotic concentrations; the boundary line increased significantly, and gene mutations conferring resistance were identified. This new method enables the rapid identification of resistant strains in the bacterial population. Use of the linear gradient plate can easily identify the precise MIC and reveal the dynamic differentiation of bacteria near the MIC. This method allows the study of genetic and physiological characteristics of individual strains, and may be useful for early warning of antibiotic resistance that may occur after use of certain antimicrobial agents, and guide clinical treatment. 
Determining the antibiotic susceptibility of pathogenic bacteria is an important function of clinical microbiology laboratories. For that reason, the Clinical and Laboratory Standard Institute (CLSI) and similar organizations have established reference standards for antibiotic susceptibility testing (AST) methods and for determining pharmacokinetic (PK)/pharmacodynamics (PD) breakpoints and clinical values. Using a standard testing method, we can determine the minimum inhibitory concentration (MIC) and inhibition zone diameter, which indicate whether the pathogen is sensitive or resistant to antibiotics used in clinical practice [1] [2] [3] . Over the years numerous countries around the world have been committed to the standardization of AST and surveillance of antibiotic-resistant bacteria [4] [5] [6] [7] . However, the widespread use of antibiotics has significantly increased bacterial resistance [8] [9] [10] , and the bacterial MIC far exceeds break point. For that reason, population dynamics of bacteria near the MIC is becoming an important question in the pharmacology of antibiotics. A novel method to precisely determine MICs is urgently needed, as well as the ability to identify "super" antibiotic-resistant strains in clinical bacterial populations.
As early as 1952, Szybalski [11] empirically established a gradient plate method to isolate antibiotic-resistant bacteria, but the method was used primarily to screen resistant strains rather than for AST [12] [13] [14] . In this study, we developed an improved method designed according to Fick's laws of diffusion [11, 15] . A uniform linear increase in the antibiotic concentration along the gradient axis was verified by measuring enrofloxacin concentration on the agar surface. When heavy bacterial suspensions were spread on the agar surface and incubated for more than 12 h, the boundary between resistant colonies and the confluent growth of susceptible cells demonstrated the true MIC of enrofloxacin and enabled identification of resistant strains. This method may be useful for early warning of antibiotic resistance to guide the clinical use of antibiotics.
Materials and methods

Strain and materials
Escherichia coli ATCC 25922, enrofloxacin, 1.5% Luria Broth (LB) agar medium, 1.5% agar medium, 9-cm petri dishes, 5-mL centrifuge tubes, phosphoric acid-triethylamine buffer, fluorescence spectrophotometer meter (HITACH F4500), 96-well plates.
MIC determination of enrofloxacin to ATCC 25922 by microdilution method
According to the CLSI standard [3] , AST was performed with enrofloxacin using three dilution gradients: 1, 0. 
Determination of enrofloxacin recovery rate in the agar
A standard curve between fluorescence intensity and enrofloxacin concentration was constructed. A dilution series of 0.1, 0.01, 0.001, 0.0001, 0.00001 g mL 1 enrofloxacin solution was prepared with phosphoric acid-triethylamine buffer (pH 3.0). Fluorescence intensity was detected with a F4500 fluorescence spectrophotometer (excitation wavelength 278 nm, absorption at 446 nm, voltage 600 V) [17] . A medium containing 1.5% agar and 1, 2, 4, or 8 g mL 1 enrofloxacin was poured into 9-cm petri dishes (15 mL/dish). After the agar solidified, 10-mm circular agar blocks were removed. Each block was weighed, placed into 1 mL phosphate-triethylamine buffer (pH 3.0) in a 5-mL centrifuge tube, and heated in water bath to dissolve the agar, and then cooled. The heating and cooling steps were carried out without agitation to allow the agar to settle. The supernatant was used to measure fluorescence intensity of enrofloxacin, and the concentration of each block was determined using the standard curve.
Preparation and verification of a linear gradient plate
Two layers of agar were poured into each of the 24 linear gradient plates. A bottom layer consisting of 15 mL LB agar (about 55°C) with 2 g mL 1 enrofloxacin was allowed to harden in the form of a wedge with the plate slanted such that the entire bottom was just covered. The tilt direction was marked with an arrow. With the plate in the normal horizontal position, another 15 mL plain LB agar was added. After allowing vertical diffusion of the drug from the bot-tom agar surface for 12 h, the enrofloxacin concentration was diluted in proportion to the ratio of the agar layer thicknesses. In this way, the enrofloxacin gradually increased from the theoretical concentration of 0 to 2 g mL 1 along the gradient axis ( Figure 1A ). LB medium with 1.5% agar (15 mL) was poured into 9-cm petri dishes and solidified. Then 10-mm circular agar blocks were removed, weighed, and affixed to the solidified linear gradient plate surface equidistant along the tilt axis in three rows with seven blocks per row ( Figure 1B ). The 24 gradient plates were then incubated at 37°C. Every hour, all the blocks on one of the plates were removed, and each block was placed into 1 mL phosphoric acid-triethylamine buffer (pH 3.0) in a 5-mL centrifuge tube to determine the enrofloxacin concentration. The plate in which the natural boundary appeared in the middle was selected. The distance from the lowest concentration point to the boundary along the tilt axis was measured. MIC was calculated according to the linear gradient relationship and antibiotic concentration.
Determination of enrofloxacin MIC against E. coli
Characteristics of the inoculum spread on the gradient plate
All the discrete colonies (large and small) and some samples of bacteria from the area of dense confluent growth were inoculated into antibiotic-free liquid medium, incubated for 12 h, and then spread onto a higher concentration gradient plate. Bacterial growth and colony location were then analyzed. In addition, the quinolone resistance-determining regions of gyrA, gyrB, and parC, parE were amplified from the total DNA of each colony, and mutations related to drug-resistance were analyzed ( 
Results
Determination of enrofloxacin MIC against E. coli ATCC 25922 using the microdilution method
As indicated in Figure 2 , the three different gradients of double-dilution enrofloxacin produced three different MIC results by the microdilution method. The finding 0.025 g mL 1 was most accurate, but was obtained using an artificially set gradient. When the tested strain possesses high resistance, such artificially set gradient will produce greater errors in the estimated MIC. In addition, this method cannot differentiate resistant strains from the susceptible strains in the bacterial population.
Determination of enrofloxacin MIC against E. coli ATCC 25922 using the agar dilution method
This method also uses an artificially set gradient. However, the drug-resistant strains can be isolated using the plates prepared with specific antibiotic concentrations. As shown in Figure 3 , the MIC was 0.0625 g mL 1 when 1200 CFU inoculum was used, but increased to 0.125 g mL 1 with 10 8 CFU. The problems associated with the two common AST methods recommended by CLSI were discussed in detail in our review [19] .
Determination of enrofloxacin MIC against E. coli ATCC 25922 using the CKC method
The bactericidal effect according to enrofloxacin concentration was fully described by the CKC (Figure 4) , with BC 50 =0.0205 g mL 1 and BC 1 =0.0364 g mL 1 . Fitting the data eliminated the error introduced by the artificial gradient. However, the gradient was stepwise, not linear. Discrete colonies were obtained only between BC 1 and BC 50 . We can rule out the emergence of mutant colonies, because inoculums were less than 1000 CFU to facilitate colony counting [17] .
Determination and verification of linear enrofloxacin concentration on the gradient plate surface
The standard curve of enrofloxacin concentration and fluorescence intensity, y=52666x+306.2, showed a strong linear correlation (R 2 =0.998). The recovery rate of enrofloxacin from agar blocks was 99%, indicating that the agar (1.5%, w/v) did not absorb significant amounts of enrofloxacin.
The time-concentration curves in Figure 5 show that enrofloxacin concentrations in different regions of the gradient plate surface increased rapidly over time. The higher enrofloxacin concentration in the bottom agar layer diffused more rapidly. After 12 h, the enrofloxacin concentration at each point stabilized, and concentration-distance curves could be fitted with a linear equation (Figure 6 ). In this way, the drug concentration at any point on the agar surface along the gradient could be accurately determined.
Determination of enrofloxacin MIC against E. coli ATCC 25922 using the gradient plate
In the gradient plate prepared with 0.03125 g mL 1 enrofloxacin (bottom agar layer), two distinct regions were observed: an area of continuous dense growth and an area of discrete colonies ( Figure 7A ). The boundary concentration was MIC=0.018 g mL 1 . The gradient plate thus displayed continuous changes of the population regarding colony formation and regional distribution under increasing drug concentrations. This technique is a simple and intuitive method to visualize the CKC. Furthermore, it can identify resistant strains in the bacterial population for further genetic and physiologic analysis. With increasing inoculum amounts, the number of discrete large colonies increased, but the location of the MIC line was unaltered (data not shown).
Characteristics of the inoculum spread on the gradient plate
Bacteria from three different locations of the continuous growth area were sampled, and three discrete large colonies and three discrete small colonies ( Figure 7A ) were also selected for analysis. These samples were inoculated separately into liquid LB medium, incubated for 8 h, and then spread onto new gradient plates with different antibiotic concentrations. Figure 7B shows that when bacteria from the continuous dense area were spread onto the same concentration gradient plate, the distribution of the colonies was consistent with that of Figure 7A , indicating that the characteristics of the susceptible bacteria were not influenced by the drug. Resistant strains in the original population, which were inhibited by the more numerous susceptible cells in the areas of continuous dense growth, formed large discrete colonies in the areas of higher antibiotic concentration.
Bacteria from the small colonies were then spread onto gradient plates prepared with 0.125 g mL 1 enrofloxacin.
The colony distribution pattern was also consistent with Figure 7A , but the boundary concentration was four times higher ( Figure 7C ). Spreading the large discrete colonies on plates prepared with 0.125 g mL 1 enrofloxacin produced a similar pattern; however, the boundary concentration was 16 times higher ( Figure 7D ). None of the colonies analyzed showed gene mutations in gyrB, parC, or parE. However, mutations were found in amino acid 87 of gyrA: GGC→TAC, glycine→tyrosine (small discrete colonies); GGC→TAC, glycine→tyrosine (two large discrete colonies); and GGC→GAC, glycine→ Figure 7A onto a gradient plate prepared with 0.03125 g mL 1 enrofloxacin. C, Distribution of colonies after spreading bacteria from three small discrete colonies shown in Figure 7A onto a gradient plate prepared with 0.125 g mL 1 enrofloxacin. D, Distribution of colonies after spreading bacteria from three large discrete colonies shown in Figure 7A onto a gradient plate prepared with 0.5 g mL 1 enrofloxacin.
aspartic acid (one large discrete colony).
Discussion
Problems with current AST methods and standards pro-posed by CLSI were previously discussed [19] . The disk diffusion method recommended by the World Health Organization is easy and has been widely used for nearly 40 years [2] [3] [4] . The E-test and spiral gradient endpoint method have been used for more than 20 years, but are still expensive because the technology is protected by patent [20, 21] . In both methods, the drug diffuses into the agar plate in a three-dimensional hemispherical manner. The non-linear gradient diffusion and different physical and chemical properties of drug molecules are difficult to fit with a universal model [22] [23] [24] [25] [26] . The antibiotic concentration at the edge of the inhibition zone cannot be used to determine MIC, and using the diameter is also a poor indicator of MIC; therefore, MIC is rarely reported using these methods. The Kirby-Bauer method was established to determine the linear relationship between the inhibition zone diameter and MIC. However, there is not a one-to-one correspondence; when testing a large number of strains, one inhibition zone diameter may correspond to more than one MIC, and vice versa. Because testing conditions (e.g., drug disk size drug dosage, bacterial inoculum, agar concentration, incubation time, and temperature) affect formation of the inhibition zone, improvement of the agar dilution method has been discussed for many years [27] [28] [29] [30] [31] [32] .
It is difficult to produce a continuous linear gradient using the agar dilution method; the measured concentration is a range of concentrations. The same problem exists when determining the mutation prevention concentration (MPC) for single-step mutants [33] . The CKC method was proposed to describe dynamic changes in bacterial populations exposed to linear concentration increases of a drug. The CKC from BC 99 to BC 1 can be used to calculate the BC 50 and other parameters [17, 34, 35] . The differential analysis method is based on turbidity to exclude the interference of resting cells in the bacterial population. This technique can be combined with a two-dimensional contour map to show the effects of drug concentration and time [36] . Both methods can provide important information for PK/PD analysis [37, 38] .
These conventional methods have the same problem in that they cannot directly determine the precise MIC, but produce mixed populations or colonies at the concentration near the MIC. It is impossible to isolate strains that are resistant to concentrations just above the MIC. However, use of linear gradient agar plates solves these difficulties.
Fick's laws of diffusion characterize the one-dimensional diffusion of small molecules in a homogeneous liquid phase. This is expressed as
in which D is the diffusion coefficient, C is the solute concentration, x is diffusion displacement, and t is diffusion time [15, 39] . The drug concentration at all points in the bottom agar layer C is the same before the upper agar layer is added. After the upper layer is poured, the molecules diffuse in the direction perpendicular to the slope of the bottom agar layer. Over time, In this paper, LB agar plates containing linear gradients of enrofloxacin were prepared. The diffusion equilibrium was approached at 12 h, and the stable linear gradient was verified. When a large amount of bacteria was grown on the gradient plates, two types of colonies were observed in two different areas of the plate, thereby allowing the accurate determination of enrofloxacin MIC. Two types of mutant strains were isolated from the discrete colonies.
The linear gradient plate method provides significant advantages and shows potential for use in antibiotic resistance research and clinical AST.
(i) Accurate determination of the MIC. The bacterial population naturally forms two regions on the gradient plate. The boundary between the two regions provides an accurate assessment of the MIC. This method is superior to the artificial dilution series in tubes or the agar dilution method, particularly when evaluating high-resistant strains. The linear gradient plate and CKC methods are different approaches that provide equally satisfactory estimates of the bactericidal effect and resistance of the population exposed to a continuous linear gradient of enrofloxacin. The BC 50 (0.0205 g mL 1 ) and boundary concentration (0.018 g mL 1 ) were very close and were equivalent to the smallest MIC (0.025 g mL 1 ) of the microdilution assay. However, of the three results, the concentration at the natural boundary (0.018 g mL 1 ) is a more accurate MIC of the dominant population. For example, when the bacterial inoculum increased (Figure 3) , the inhibitory concentration appeared to increase, as assessed by the number of colonies in the agar dilution method. We were unable to determine the CKC (Figure 4 ) since the bacterial growth was dense, and the colonies too small to count. In contrast, the linear gradient plate reveals the precise MIC of dominant population stably.
(ii) Analysis of bacterial resistance. The heterogeneity of drug sensitivity displayed when the bacterial population increased reflects the emergence of strains with different resistance mutations and phenotypes. These discrete colonies from the region of high antibiotic concentration were spread on a new gradient plate, and a new MIC was obtained (the MPC). The mechanisms of resistance revealed the diversity of strains in the population, and resistance phenotypes were not limited to one-step mutations. The gradient plate method thus provides a new method for studying bacterial resistance phenotypes.
(iii) Early warning of drug-resistant strains may be used to determine clinical treatment. The gradient plate method can quickly identify consecutive drug-resistant strains. This method can be used to study the increase of resistant phenotypes, mutation rates, biochemical mechanisms of resistance mechanisms, and their molecular regulation.
(iv) The linear gradient plate can show individual bacteria changes of colony proliferation, reveal growth inhibition and death according to drug concentration and time, and evaluate time dependence or concentration dependence of the drug.
Based on differential equations and the contour map, we have proposed a new method to characterize the combined roles of drug concentration and treatment time. This method is suitable for laboratory studies to determine the mechanism of action and for PK/PD analysis [36] . The linear gradient plate method is simple and feasible for use in a typical clinical laboratory. The combination of the two methods enables a more comprehensive understanding of interactions between drugs and bacterial populations. However, its universality, availability, and potential clinical applications require further testing and improvement.
